ArticleExperimental and therapeutic medicine2019

BAY 87-2243 sensitizes hepatocellular carcinoma Hep3B cells to histone deacetylase inhibitors treatment via GSK-3β activation.

Yang-Ling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.